Tech Company Financing Transactions
PolarityTE Funding Round
Avenue Capital and private investors participated in a $22.5 million capital raise for PolarityTE. The round was announced on 5/22/2024.
Transaction Overview
Company Name
Announced On
5/22/2024
Transaction Type
Venture Equity
Amount
$22,500,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to advance SkinTE's Phase III Pivotal Study evaluating SkinTE in the treatment of Wagner 1 Diabetic Foot Ulcers (COVER DFUS II).
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
1960 South 4250 West
Salt Lake City, UT 84104
USA
Salt Lake City, UT 84104
USA
Phone
Undisclosed
Website
Email Address
Overview
At PolarityTE, we are focused on developing regenerative treatments for some of the most complex wounds--where disease burden on patients and families is immense and current therapeutic options are often limited or do not exist. Transform the lives of patients by unlocking the potential of personalized autologous therapy.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
John Stetson
Chief Medical Officer
Edward Swanson
Chief Operating Officer
Nikolai Sopko
VP - Operations
Ashlee Fishleigh
VP - R & D
Nicholas Baetz
VP - R & D
Marytheresa Ifediba
Browse more venture capital transactions:
Prev: 5/22/2024: SixPeaks Bio venture capital transaction
Next: 5/22/2024: Sinn Studio venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. VC investment data records reported here are derived from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs